These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16820868)

  • 1. Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth.
    Cao JG; Peng SP; Sun L; Li H; Wang L; Deng HW
    Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):514-21. PubMed ID: 16820868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma.
    Wu YH; Cao JG; Xiang HL; Xia H; Qin Y; Huang AJ; Xiao D; Xu F
    World J Gastroenterol; 2009 Apr; 15(14):1744-50. PubMed ID: 19360918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
    Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
    Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin.
    Gu Q; Sun C; Luo J; Zhang T; Wang L
    Anticancer Drugs; 2014 Oct; 25(9):1044-51. PubMed ID: 24942148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo.
    He Y; Jiang Y; Li YJ; Liu XH; Zhang L; Liu LJ; Shi H; Li HN; Ma YC; Jin XM
    J Gastroenterol Hepatol; 2010 May; 25(5):935-41. PubMed ID: 20546447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
    Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
    J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant vascular basement membrane derived multifunctional peptide blocks endothelial cell angiogenesis and neovascularization.
    Wang C; Cao J; Qu J; Li Y; Peng B; Gu Y; He Z
    J Cell Biochem; 2010 Oct; 111(2):453-60. PubMed ID: 20524205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cloning and expression of angiogenic inhibitor tumstatin(45-132) in E. coli].
    Luo YQ; Wang LH; Qiu Y; Jiao BH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):141-3. PubMed ID: 15766393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA; Luo JX; Zhang TY; Wang FY; Li RF
    Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.
    Yao B; He QM; Tian L; Xiao F; Jiang Y; Zhang R; Li G; Zhang L; Hou JM; Wang L; Cheng XC; Wen YJ; Kan B; Li J; Zhao X; Hu B; Zhou Q; Zhang L; Wei YQ
    Hum Gene Ther; 2005 Sep; 16(9):1075-86. PubMed ID: 16149906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
    Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
    Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.